Health
Multi-center Phase I study of anti-VISTA opens for patient enrollment – News-Medical.Net
Dartmouth and Dartmouth-Hitchcock Norris Cotton Cancer Center will serve as one of the lead institutions for a new multi-center clinical trial of anti-VISTA, no…
Reviewed by Emily Henderson, B.Sc.Oct 7 2020
Dartmouth and Dartmouth-Hitchcock Norris Cotton Cancer Center (NCCC) will serve as one of the lead institutions for a new multi-center clinical trial of anti-VISTA, now open and recruiting for patient enrollment. The trial is a Phase I study of CI-8993, an anti-VISTA (V-domain Ig Suppressor of T-cell Activation) antibody, in adult patients with advanced solid tumors.
VISTA is a checkpoint regulator whose function is to prevent activation of the immu…
-
General20 hours agoDid my Coalition policy launch dream come true, and other thoughts
-
General19 hours agoDozens dead in Ukraine’s Sumy after Russian strike, acting mayor says
-
General23 hours agoOut-of-control bushfire in central Victoria within 100m of private property
-
Noosa News7 hours agoWoman dies, 10 rushed to hospital after Bald Hills collision